Morphinan derivative and its pharmaceutical applications
CA 2105072 C · Owner: Kawai, Koji · Inventors: Endoh, Takashi; Kawamura, Kuniaki; Nagase, Hiroshi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
There is disclosed morphinan derivative represented by the general formula (I) or its pharmacologically acceptable acid addition salt:, (see fig. I), ~ represents a single or double bond. R1 represents an alkyl group having 1-5 carbon atoms, a cycloalkylalkyl group having 4-7 carbon atoms, a cycloalkenylalkyl group having 5-7 carbon atoms, an aryl group having 6-12 carbon atoms an, aralkyl group having 7-13 carbon atoms an alkenyl group having, 4-7 carbon atoms an allyl group, a furan-2-ylalkyl group having 1-5 carbon atoms, or a thiophen-2-ylalkyl group having 1-5 carbon atoms. R2 represents a hydrogen atom a hydroxy, group, a nitro group, an alkanoyloxy group having 1-5 carbon atoms, an …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 22, 1993 and granted July 28, 1998. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 22, 2013.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 22, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.